Masimo Corporation (MASI) 59.14 $MASI Thermo Fisher

New Post Public Reply Private Reply Replies (0) Message Board

Sep 1, 2016 at 9:19 AM

Masimo Corporation (MASI) 59.14 $MASI

Thermo Fisher Closes FEI Deal, Grows in Electron Microscopy
Zacks Equity Research - Zacks Investment Research - 1 hr 37 mins ago
Thermo Fisher Scientific, Inc. (TMO) recently completed its earlier announced mega $4.2 billion acquisition of FEI Company.
BABY: 38.91 (-0.62), MASI: 59.14 (+0.15), TMO: 152.19 (unch), IDXX: 112.68 (unch)

51.3% Return Seen to Date on SmarTrend Masimo Call (MASI)
Comtex SmarTrend(R) - Thu Sep 01, 12:18AM CDT
SmarTrend identified an Uptrend for Masimo (NASDAQ:MASI) on February 26th, 2016 at $39.09. In approximately 6 months, Masimo has returned 51.29% as of today's recent price of $59.14.
MASI: 59.14 (+0.15)

Inogen Hits 52-Week High on Solid Q2 & Estimate Revision
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 8:01AM CDT
Share price of Inogen Inc (INGN) rallied to a new 52-week high of $59 on Aug 30, eventually closing a tad bit lower at $58.46.
BABY: 38.91 (-0.62), MASI: 59.14 (+0.15), INGN: 58.02 (unch), NUVA: 65.47 (unch)

Veeva Systems (VEEV) Q2 Earnings, Revenues Top; View Up
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 7:57AM CDT
Veeva Systems (VEEV) reported adjusted earnings of 15 cents per share in the second-quarter fiscal 2017, a 20.9% increase on a year-over-year basis.
VEEV: 41.25 (+0.33), BABY: 38.91 (-0.62), MASI: 59.14 (+0.15), NUVA: 65.47 (unch)

Varian Medical Excels on Growing International Footprint
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 7:46AM CDT
Varian recently announced the installation of a Clinac iX medical linear accelerator at Instituto Oncologico del Oriente Boliviano in Santa Cruz, Bolivia.
MASI: 59.14 (+0.15), VAR: 96.13 (unch), QDEL: 21.77 (+0.03), IDXX: 112.68 (unch)

PetMed Remains Strong on New Order Sales; Reorder Dips
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 9:44AM CDT
On Aug 29, 2016, we issued an updated research report on PetMed Express (PETS). This nationwide pet pharmacy presently carries a Zacks Rank #2 (Buy).
BABY: 38.91 (-0.62), MASI: 59.14 (+0.15), PETS: 20.16 (-0.21), IDXX: 112.68 (unch)

Varian Medical Hits 52 week High, Oncology Prospects Bright
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 7:56AM CDT
Share price of Varian Medical rallied to a new 52-week high of $96.31 on Aug 29.
BABY: 38.91 (-0.62), MASI: 59.14 (+0.15), VAR: 96.13 (unch), IDXX: 112.68 (unch)

BioTelemetry Gets CE Mark for Holter Monitoring Software
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 7:38AM CDT
BioTelemetry (BEAT) recently announced the receipt of CE mark for its Holter analysis software.
MASI: 59.14 (+0.15), BEAT: 18.47 (-0.51), QDEL: 21.77 (+0.03), NUVA: 65.47 (unch)

Luminex Poised on Pipeline Strength, System Sales Upbeat
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 7:19AM CDT
Austin-based Luminex (LMNX) is well poised on pipeline strength and solid system sales.
MASI: 59.14 (+0.15), QDEL: 21.77 (+0.03), LMNX: 21.07 (unch), NUVA: 65.47 (unch)

Masimo Announces Four-Year Partnership with World Federation of Societies of Anaesthesiologists (WFSA)
BusinessWire - Mon Aug 29, 6:06PM CDT
Masimo (NASDAQ: MASI) announced Sunday at the World Congress of Anaesthesiologists (WCA) in Hong Kong that it has become the first Global Impact Partner of the World Federation of Societies of Anaesthesiologists (WFSA). The four-year partnership, "Safe Anaesthesia - ASAP" (Anesthesia Safety Action Plan), will initially identify one country with poor access to safe anesthesia, and will work toward implementing programs and training designed to improve anesthesia care and safe surgery outcomes.
MASI: 59.14 (+0.15)

INC Research Upgraded to Strong Buy on Estimate Revision
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 8:26AM CDT
On Aug 27, Zacks Investment Research raised INC Research Holdings Inc. (INCR) to a Zacks Rank #1 (Strong Buy).
BABY: 38.91 (-0.62), MASI: 59.14 (+0.15), ABCO: 42.15 (-0.04), INCR: 43.63 (-0.74)

Masimo Announces a Special Worldwide Program for Total Hemoglobin (SpHb(R)) Monitoring for Areas Affected by the Zika Virus
BusinessWire - Mon Aug 29, 7:03AM CDT
Masimo (NASDAQ: MASI) announced today that in response to the Zika virus and its potential impact on the availability of blood products, Masimo is creating a special program to dramatically reduce the cost of and increase access to Masimo's continuous hemoglobin monitoring (SpHb(R)) solutions, shown to help clinicians reduce blood transfusions in both low and high blood loss surgery. This special program will be available wherever the blood supply is affected by the Zika virus.
MASI: 59.14 (+0.15)

Bioanalytical (BASI) Launches Sampling System, Stock Down
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 1:10PM CDT
Bioanalytical recently introduced the 'Embrace Automation grant program' featuring 'BASi Culex NxT Automated Blood Sampling system and Raturn.'
HYH: 36.45 (unch), MASI: 59.14 (+0.15), BASI: 1.11 (unch), IDXX: 112.68 (unch)

Abaxis Hurt by Dismal Q1 Results & Fierce Competition
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 7:32AM CDT
Abaxis' (ABAX) first-quarter fiscal 2017 results disappointed us, with the company squarely missing the Zacks Consensus Estimate.
BABY: 38.91 (-0.62), MASI: 59.14 (+0.15), ABAX: 50.14 (unch), IDXX: 112.68 (unch)

Cigna Okays 3D Mammogram: Is Hologic Poised to Gain?
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 6:55AM CDT
Hologic's (HOLX) Genius 3D mammogram is the only clinically proven test to detect cancer 15 months earlier than traditional 2D screenings.
BABY: 38.91 (-0.62), MASI: 59.14 (+0.15), IDXX: 112.68 (unch), HOLX: 38.42 (-0.04)

Patterson Companies (PDCO) Q1 Earnings Meet Estimates
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 2:55PM CDT
Patterson Companies reported first-quarter fiscal 2017 adjusted earnings of 51 cents per share, in line with the Zacks Consensus Estimate.
HYH: 36.45 (unch), MASI: 59.14 (+0.15), PDCO: 46.00 (unch), IDXX: 112.68 (unch)

Masimo Has Returned 49.7% Since SmarTrend Recommendation (MASI)
Comtex SmarTrend(R) - Wed Aug 24, 12:45PM CDT
SmarTrend identified an Uptrend for Masimo (NASDAQ:MASI) on February 26th, 2016 at $39.09. In approximately 6 months, Masimo has returned 49.65% as of today's recent price of $58.50.
MASI: 59.14 (+0.15)

PRA Health Sciences (PRAH) Hits 52-Week High on Solid Q2
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 7:59AM CDT
Share price of PRA Health Sciences (PRAH) rallied to a new 52-week high of $52.72 on Aug 23, eventually closing a tad bit higher at $52.59.
MASI: 59.14 (+0.15), PRAH: 50.55 (-0.26), CRY: 15.95 (-0.11), NUVA: 65.47 (unch)

BioTelemetry Forms Partnership with Bloomlife, Stock Down
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 7:57AM CDT
BioTelemetry announced a strategic partnership with Bloom Technologies.
MASI: 59.14 (+0.15), BEAT: 18.47 (-0.51), CRY: 15.95 (-0.11), NUVA: 65.47 (unch)

5 Medical Device Stocks to Buy on Q2 Earnings
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 9:22AM CDT
We have picked five stocks on solid Zacks Rank.
ISRG: 686.42 (-1.11), BABY: 38.91 (-0.62), MASI: 59.14 (+0.15), IDXX: 112.68 (unch), CRY: 15.95 (-0.11)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Employment Law Suit Hits ABC: Alleged Wage Violations

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Viking Ventures: Impacts of VK2735 on Obesity Examined

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

D-Wave Quantum Hit with Securities Fraud Lawsuit

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

CVS Study: GLP-1 Drugs Effective But Costly

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...